ProMIS Neurosciences is trading at $13.34 (5.7% down) today. - The decline follows fresh reports of Janus Henderson Group PLC acquiring a 14.41% stake in the company during the first quarter, valued at approximately $16.4 million. - The stock's movement today is also observed amidst mentions of the company's Q1 earnings per share missing estimates by $0.20. - This idiosyncratic sell-off occurs as the broader U.S. indices are generally rising.